4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001104659-21-039056
Options or other derivatives
- Director sold 81,872 shares at an average $0.27 ($22,132)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| NEIS JOHN Director | 2021-03-17 | Sale · Series A Warrants | −58,640 | $0.28 | $16,273 | 23,232 | D |
| NEIS JOHN Director | 2021-03-18 | Sale · Series A Warrants | −23,232 | $0.25 | $5,859 | 0 | D |
Loading xslF345X03/tm2110277d1_4seq1.xml…